Determinación del valor clínico de los niveles en sangre de TIM-3, Galectina-9, y marcadores de anemia e inflamación en pacientes con cáncer cervicouterino
LJ Serna Villalobos - 2022 - repositorioinstitucional.buap.mx
Abstract" El cáncer cervicouterino (CaCu) se ubica en el segundo lugar como causa de
muerte por neoplasias malignas en la mujer mexicana. El mal manejo clínico y terapéutico …
muerte por neoplasias malignas en la mujer mexicana. El mal manejo clínico y terapéutico …
Disease characteristics and treatment attributes of patients admitted to the oncology ward of a tertiary care government hospital
LCV Suhag, LCBS Sunita, MP Vats… - Journal of Cancer …, 2017 - journals.lww.com
Background: The burden of oncology patients in the most developing countries including
India has witnessed a steady, progressive, and significant upward trend attributed mainly to …
India has witnessed a steady, progressive, and significant upward trend attributed mainly to …
Incidence of anemia in non-hematologic malignancy patients treated with systemic chemotherapy in Bangkok Metropolitan Administration General Hospital.
C Jatuparisuthi, W Ratnaothai - The Journal of Prapokklao …, 2010 - he02.tci-thaijo.org
Objective: To evaluate the incidence of chemotherapy-related anemia and determine risk
factors of anemia in non-hematologic malignancy patients. Method: This study was …
factors of anemia in non-hematologic malignancy patients. Method: This study was …
[引用][C] Hubungan Status Gizi dan Jenis Obat Kemoterapi terhadap Kejadian Anemia pada Pasien Kanker Payudara di Rsud Al-Ihsan
KN Rahmayanti, TH Rahim, AF Sumantri - Prosiding Pendidikan Dokter, 2021